[Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors].
D001932:Brain Neoplasms / Q000628:therapy; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000628:therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy; D008795:Metronidazole / Q000627:therapeutic use*; D008920:Misonidazole / Q000627:therapeutic use; D009062:Mouth Neoplasms / Q000628:therapy; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D012004:Rectal Neoplasms / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000628:therapy; D014594:Uterine Neoplasms / Q000628:therapy
D011838:Radiation-Sensitizing Agents; D008795:Metronidazole; D008920:Misonidazole
Elektronoaktseptornye soedineniia, kak radiosensibilizatory gipoksicheskikh kletok opukholeĭ cheloveka.